Embarking on the CAR-T Journey

In this exclusive PC Podcast interview, Renier Brentjens, MD, PhD, deputy director and chair of medicine at the Roswell Park Comprehensive Cancer Center, discusses how he has seen the field evolve since its inception, and what excites him most about its future; how the Roswell Park expansion helps improve patient access to CAR T-cell therapy; the key safety concerns associated with CAR T-cell therapy, along with how Roswell Park is working to mitigate potential risks; how Roswell Park working to make CAR T-cell therapy more widely available; and the steps needed to be taken at the regulatory and healthcare policy levels in order to support the broader adoption of CAR T-cell therapy.